| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T50 |
0-161 |
Sentence |
denotes |
Collectively, the goal of antiviral therapeutics is to inhibit one or more events in the life cycle of the virus in order to impede the propagation of infection. |
| T51 |
162-309 |
Sentence |
denotes |
Along these lines, any protein or event in the virus life cycle can be considered as a molecular target for anti-COVID-19 drug development efforts. |
| T52 |
310-478 |
Sentence |
denotes |
In this review, we describe the antiviral agents that are currently being tested in clinical trials to block and/or inhibit the advanced events of the virus life cycle. |
| T53 |
479-657 |
Sentence |
denotes |
Although the majority of the presented antiviral therapeutics target the viral polymerase or the viral proteases, few other therapeutics target other molecular targets (Table 1). |
